|
Report Date : |
22.07.2014 |
IDENTIFICATION DETAILS
|
Name : |
PHARMERA GOTHIA PHARMACEUTICAL AB |
|
|
|
|
Registered Office : |
Elis Nilssons väg 7, Hus 26, 27139 YSTAD |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
2013 |
|
|
|
|
Date of Incorporation : |
14.07.2004 |
|
|
|
|
Com. Reg. No.: |
5566640693 |
|
|
|
|
Legal Form : |
Limited liability company |
|
|
|
|
Line of Business : |
Wholesale of pharmaceutical goods |
|
|
|
|
No. of Employees |
02 (2013) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
Aided by peace and neutrality for the whole of the 20th
century,
|
Source
: CIA |
|
Business Name |
PHARMERA GOTHIA
PHARMACEUTICAL AB |
|
Country |
SWEDEN |
|
Company Registration Number |
5566640693 |
|
Main Activity |
Wholesale of pharmaceutical goods |
|
Activity Code |
46460 |
|
Company Status |
Active |
|
Latest Turnover Figure |
29.277.000 |
|
Latest Shareholder Equity Figure |
2.822.000 |
|
Current Directors |
|||
|
Name |
Appointment Date |
Position |
|
|
Paul Robert Nilsson |
10/09/2011 |
Chairman of Board |
|
|
Gustaf Sverker Nilius Littorin |
17/09/2009 |
Actual Member of Board |
|
|
Lars Bernhard Rydja |
10/09/2011 |
Actual Member of Board |
|
|
Patrik Robert Nilsson |
17/09/2009 |
Actual Member of Board |
|
|
Previous Directors |
|||
|
Name |
Appointment Date |
Position |
Resignation Date |
|
Fredrik Ivan Mikael Eckersten |
17/09/2009 |
Chairman of Board |
|
|
Patrik Robert Nilsson |
27/08/2009 |
Substitute |
|
|
Paul Robert Nilsson |
17/09/2004 |
Actual Member of Board |
|
|
Lars Bernhard Rydja |
17/09/2004 |
Actual Member of Board |
|
No negative information found
|
Issued Share Capital |
101.500 |
|
Debt balance at the Swedish Enforcement Agency |
|
|
Number of Private Claims |
- |
|
Balance of Private Claims |
- |
|
Number of Public Claims |
- |
|
Balance of Public Claims |
- |
|
Total Balance |
- |
|
Record of non-payment |
|
|
Number of distraint attempts and repossessions |
- |
|
Number of public claims |
- |
|
Number of private claims |
- |
|
Number of applications for an order to pay |
- |
|
Number of reclaimed/revoked applications |
- |
|
No group structure for this company. |
|
PROFIT AND LOSS |
|||
|
Financial Year |
2013 |
2012 |
2011 |
|
Number of Weeks |
52 |
52 |
52 |
|
Currency |
SEK |
SEK |
SEK |
|
Consolidated Accounts |
N |
N |
N |
|
Revenue |
29.280.000 |
24.860.000 |
4.943.000 |
|
Operating Costs |
27.791.000 |
23.336.000 |
6.471.000 |
|
Operating Profit |
1.489.000 |
1.524.000 |
-1.528.000 |
|
Wages & Salaries |
-824.000 |
-347.000 |
-483.000 |
|
Depreciation |
-47.000 |
-140.000 |
- |
|
Financial Income |
- |
125.000 |
589.000 |
|
Financial Expenses |
-194.000 |
-226.000 |
-1.430.000 |
|
Extraordinary Income |
- |
- |
- |
|
Extraordinary Costs |
-194.000 |
-226.000 |
-1.430.000 |
|
Profit before Tax |
1.295.000 |
1.447.000 |
-2.369.000 |
|
Tax |
- |
- |
- |
|
Profit after Tax |
1.295.000 |
1.447.000 |
-2.369.000 |
|
Minority Interests |
- |
- |
- |
|
Other Appropriations |
- |
- |
- |
|
Retained Profit |
1.295.000 |
1.447.000 |
-2.369.000 |
|
BALANCE SHEET |
|||
|
Financial Year |
2013 |
2012 |
2011 |
|
Number of Weeks |
52 |
52 |
52 |
|
Currency |
SEK |
SEK |
SEK |
|
Consolidated Accounts |
N |
N |
N |
|
Land & Buildings |
0 |
0 |
0 |
|
Plant & Machinery |
0 |
0 |
0 |
|
Other Tangible Assets |
0 |
0 |
0 |
|
Total Tangible Assets |
0 |
0 |
0 |
|
Goodwill |
0 |
0 |
0 |
|
Other Intangible Assets |
0 |
0 |
0 |
|
Total Intangible Assets |
0 |
0 |
0 |
|
Loans To Group |
0 |
0 |
0 |
|
Other Loans |
0 |
0 |
0 |
|
Miscellaneous Fixed Assets |
2.400.000 |
2.400.000 |
2.875.000 |
|
Total Other Fixed Assets |
2.400.000 |
2.400.000 |
2.875.000 |
|
TOTAL FIXED ASSETS |
2.400.000 |
2.400.000 |
2.875.000 |
|
Work In Progress |
0 |
0 |
0 |
|
Other Inventories |
245.000 |
271.000 |
10.000 |
|
Total Inventories |
245.000 |
271.000 |
10.000 |
|
Trade Receivables |
0 |
659.000 |
0 |
|
Group Receivables |
0 |
0 |
0 |
|
Miscellaneous Receivables |
245.000 |
510.000 |
648.000 |
|
Total Receivables |
245.000 |
1.169.000 |
648.000 |
|
Cash |
1.648.000 |
188.000 |
84.000 |
|
Other Current Assets |
0 |
0 |
0 |
|
TOTAL CURRENT ASSETS |
2.138.000 |
1.629.000 |
742.000 |
|
TOTAL ASSETS |
4.538.000 |
4.029.000 |
3.617.000 |
|
Trade Payables |
1.305.000 |
239.000 |
112.000 |
|
Bank Liabilities |
0 |
0 |
0 |
|
Group Payables |
0 |
0 |
102.000 |
|
Miscellaneous Liabilities |
411.000 |
255.000 |
305.000 |
|
TOTAL CURRENT LIABILITIES |
1.716.000 |
494.000 |
519.000 |
|
Bank Liabilities Due After 1 Year |
0 |
2.008.000 |
3.020.000 |
|
Other Loans Or Finance Due After 1 Year |
0 |
0 |
0 |
|
Group Payables After 1 Year |
0 |
0 |
0 |
|
Miscellaneous Liabilities Due After 1 Year |
0 |
0 |
0 |
|
TOTAL LONG TERM LIABILITIES |
0 |
2.008.000 |
3.020.000 |
|
TOTAL LIABILITIES |
1.716.000 |
2.502.000 |
3.538.000 |
|
Called Up Share Capital |
102.000 |
100.000 |
100.000 |
|
Share Premium |
0 |
0 |
0 |
|
Revenue Reserves |
1.904.000 |
609.000 |
-965.000 |
|
Other Reserves |
816.000 |
818.000 |
944.000 |
|
TOTAL SHAREHOLDERS EQUITY |
2.822.000 |
1.527.000 |
79.000 |
|
OTHER FINANCIALS |
|||
|
Contingent Liabilities |
807.000 |
0 |
0 |
|
Working Capital |
422.000 |
1.135.000 |
223.000 |
|
Net Worth |
2.822.000 |
1.527.000 |
79.000 |
|
RATIOS |
|||
|
Pre-Tax Profit Margin |
4.42 % |
5.82 % |
-47.93 % |
|
Return On Capital Employed |
20.71 % |
31.99 % |
-57.28 % |
|
Return On Total Assets Employed |
28.54 % |
35.91 % |
-65.50 % |
|
Return On Net Assets Employed |
45.89 % |
94.76 % |
-2998.73 % |
|
Sales/Net Working Capital |
69.38 |
21.90 |
22.17 |
|
Stock Turnover Ratio |
0.84 % |
1.09 % |
0.20 % |
|
Debtor Days |
0.00 |
9.68 |
0.00 |
|
Creditor Days |
16.27 |
3.51 |
8.27 |
|
Current Ratio |
1.25 |
3.30 |
1.43 |
|
Liquidity Ratio/Acid Test |
1.10 |
2.75 |
1.41 |
|
Current Debt Ratio |
0.61 |
0.32 |
6.57 |
|
Gearing |
|
131.50 % |
3822.78 % |
|
Equity In Percentage |
131.99 % |
93.74 % |
10.65 % |
|
Total Debt Ratio |
0.61 |
1.64 |
44.78 |
N/a
|
Basic Information |
|
|
Business Name |
Pharmera Gothia Pharmaceutical AB |
|
Registered Company Name |
Pharmera Gothia Pharmaceutical AB |
|
Company Registration Number |
5566640693 |
|
Country |
SWEDEN |
|
VAT Registration Number |
SE556664069301 |
|
Date of Company Registration |
14/07/2004 |
|
Legal Form |
Limited liability company |
|
Currency of this Report |
SEK |
|
Principal Activity Description |
Bolaget skall bedriva handel, såväl import som export, med läkemedel och därmed förenlig verksamhet. |
|
Contact Address |
Elis Nilssons väg 7, Hus 26, 27139 YSTAD |
|
Contact Telephone Number |
0411-66860 |
|
Activities |
|
|
Activity Code |
Activity Description |
|
46460 |
Wholesale of pharmaceutical goods |
|
Main Address |
||
|
Address |
Country |
Telephone |
|
Elis Nilssons väg 7, Hus 26, 27139 YSTAD |
SWEDEN |
0411-66860 |
|
Other Address |
|
|
Address |
Country |
|
No other addresses for this company. |
|
|
Email Addresses |
|
No information for this company. |
|
Web Pages |
|
No information for this company. |
|
Employee
Information |
|
|
Year |
Number of Employees |
|
2013 |
2 |
|
2012 |
1 |
|
2011 |
1 |
|
2010 |
1 |
|
2009 |
2 |
|
Advisors |
|
|
Auditor Name |
Ulf Strauss |
|
Tax Registrations |
|
|
Registered for FTax |
Yes |
|
Registered for VAT |
Yes |
|
Registered for Employee Tax |
Yes |
|
Certificates |
||
|
Type |
Category |
Issuer |
|
No certificate information for this company. |
|
|
|
Event History |
|
|
Event Date |
Event Description |
|
09/07/2014 |
Annual account, new |
|
04/07/2014 |
Annual report (PDF), new |
|
21/03/2014 |
Group Structure Change |
|
23/08/2013 |
Annual account, new |
|
30/07/2013 |
Annual report (PDF), new |
|
13/11/2012 |
Share capital, new issue |
|
27/07/2012 |
Annual account, new |
|
11/07/2012 |
Annual report (PDF), new |
|
13/09/2011 |
Authorised signatories amended or new/amended vacancy text |
|
13/09/2011 |
Company representatives, changed |
|
13/09/2011 |
Board, changed |
|
05/07/2011 |
Annual account, new |
|
22/06/2011 |
Annual report (PDF), new |
|
29/03/2011 |
Phone number, new |
|
08/02/2011 |
Authorised signatories amended or new/amended vacancy text |
|
08/02/2011 |
Board, changed |
|
08/02/2011 |
Company representatives, changed |
|
20/08/2010 |
Annual account, new |
|
06/08/2010 |
Annual report (PDF), new |
|
25/09/2009 |
Board, changed |
|
25/09/2009 |
Company representatives, changed |
|
18/09/2009 |
Authorised signatory, changed |
|
18/09/2009 |
Board, changed |
|
18/09/2009 |
Company representatives, changed |
|
28/08/2009 |
Authorised signatory, changed |
|
28/08/2009 |
Board, changed |
|
28/08/2009 |
Company representatives, changed |
|
20/08/2009 |
Company representatives, changed |
|
20/08/2009 |
Authorised signatory, changed |
|
20/08/2009 |
Board, changed |
N/a
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.19 |
|
|
1 |
Rs.102.87 |
|
Euro |
1 |
Rs.81.48 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.